Swedbank Ab Royalty Pharma PLC Transaction History
Swedbank Ab
- $77.1 Billion
- Q3 2024
A detailed history of Swedbank Ab transactions in Royalty Pharma PLC stock. As of the latest transaction made, Swedbank Ab holds 11,027,370 shares of RPRX stock, worth $300 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
11,027,370
Previous 10,813,470
1.98%
Holding current value
$300 Million
Previous $285 Million
9.4%
% of portfolio
0.4%
Previous 0.39%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
404Shares Held
290MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.2 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$626 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$445 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$325 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.9B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...